LLY - Eli Lilly
After seeing how ineffective and poorly prepared the medicine of his day was, Colonel Eli Lilly did something about it in 1876 when he founded research company in Indianapolis, Indiana named Johnson & Lilly.
Eli Lilly (NYSE:LLY) now operates primarily in one business sector: Pharmaceutical Products. It does have a secondary and smaller footprint in the animal health business segment too.
The company continues to research, develop, manufacture and market pharmaceutical products, now on an international scale. Distributing of their products is done mostly through independent wholesalers, although they do participate in some direct sales to pharmicies.
Acquisitions by Eli Lilly include IVAC Corp., SGX Pharmaceuticals, Inc., ImClone Systems Inc., Elizabeth Arden and Icos. The latter two have since been sold.
Other growth for Eli Lilly has come through a number of strategic partnerships, where licensing and development agreements have been made. Some of those include TransPharma Medical Ltd., BioMS Medical Corp. and MacroGenics, Inc.
Eli Lilly was first listed on the New York Stock Exchange in 1952.
The company was founded in 1876 and is based in Indianapolis, Indiana.
Stock Symbol / Ticker: